For appropriate patients faced with relapsed/refractory multiple myeloma
Forge ahead
with a bold approach
Target BCMA for RRMM
BLENREP is the first and only BCMA-targeted ADC monotherapy. So you can offer your RRMM patients a different option.1
ADC=antibody-drug conjugate; BCMA=B-cell maturation antigen; RRMM=relapsed or refractory multiple myeloma.